Los puntos clave no están disponibles para este artículo en este momento.
Dysregulated immune response plays a critical role in SLE, including innate immunity and adaptive immunity. Biologic agents that aim to specifically target abnormal immune processes were assessing and may bring new hope to SLE patients.
Pan et al. (Fri,) studied this question.